Corticosteroid formulation

Details Corticosteroid formulation Corticosteroid formulation

A - Human Necessities

61

K

A61K 31/57 (2006.01) A61K 9/28 (2006.01) A61K 9/50 (2006.01) A61K 31/58 (2006.01) A61P 5/44 (2006.01) A61P 19/02 (2006.01)

Patent

CA 2361503

A unit dose formulation comprising 0.25 to 2 mg of a corticosteroid. This small dose can be used to treat rheumatoid arthritis, especially if adapted to release at least 90 % by weight of the corticosteroid, 2 to 8 hours after administration.

L'invention concerne une formulation en dose unitaire comprenant entre 0,25 et 2 mg d'un corticostéroïde. Cette faible dose peut être utilisée dans le traitement de l'arthrite rhumatoïde, notamment lorsqu'elle est conçue pour libérer au moins 90 % en poids du corticostéroïde, de 2 à 8 heures après son administration.

Affiliated with

Also associated with

Rating

Corticosteroid formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Corticosteroid formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Corticosteroid formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1629840